Axillary intra-aortic balloon pump (axi-IABP) support has emerged as an alternative to femoral access for patients with advanced heart failure, offering improved mobility and potential benefits in pretransplant conditioning; however, data on associated complications remain limited. We conducted a retrospective study of 55 patients who underwent axi-IABP placement between January 2019 and July 2025 at our institution. The cohort had a median age of 59 (interquartile range [IQR], 52–65) years and presented with cardiogenic shock requiring mechanical circulatory support (MCS). Axi-IABP successfully bridged 87.3% of patients to advanced therapies. A total of 83 complications were identified in 60.0% of patients, most commonly malposition in 23.6% of patients, gas leak alarms in 16.4% of patients, and kinking in 16.4% of patients. Serious vascular complications were infrequent. The median time to first complication was 10.5 (IQR, 2.75–25.5) days. Female sex was associated with a higher hazard of first complication when controlled for height (adjusted hazard ratio [HR] = 2.75, 95% confidence interval [CI] = 1.04–7.27; p = 0.041). In conclusion, axi-IABP is an effective bridging strategy that enhances patient mobility but is associated with a high rate of device-related complications, predominantly mechanical in nature, underscoring the importance of careful patient selection and monitoring.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: